Views & Analysis What next for joint working that really improves patient out... Joint working has become something of the norm in the last decade, but have we taken the time to step back, take stock and see if we are doing it right?
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face